Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1996
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 2
1999 2
2000 4
2001 3
2002 5
2003 3
2004 2
2005 3
2006 6
2007 4
2008 1
2009 2
2010 2
2011 5
2012 1
2013 6
2014 4
2015 3
2016 6
2017 2
2018 3
2019 8
2020 4
2021 3
2022 7
2023 4
2024 12
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: cebrian a. Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11. Br J Cancer. 2024. PMID: 38467828 Free PMC article.
POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma.
Del Puerto-Nevado L, Fernández-Aceñero MJ, Cebrián A, Fatych Y, Díez-Valladares LI, Pérez-Aguirre E, de la Serna S, García-Botella A, Martínez-Useros J, García-Foncillas J, Mateos-Gómez PA. Del Puerto-Nevado L, et al. Among authors: cebrian a. Front Oncol. 2024 Oct 7;14:1433179. doi: 10.3389/fonc.2024.1433179. eCollection 2024. Front Oncol. 2024. PMID: 39435280 Free PMC article.
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
Corral JM, Puerto-Nevado LD, Cedeño M, Río-Vilariño A, Mahillo-Fernández I, Galeano C, Baños N, García-Foncillas J, Dómine M, Cebrián A. Corral JM, et al. Among authors: cebrian a. Biomed Pharmacother. 2022 Dec;156:113987. doi: 10.1016/j.biopha.2022.113987. Epub 2022 Nov 8. Biomed Pharmacother. 2022. PMID: 36411654 Free article.
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: cebrian a. Br J Cancer. 2024 May;130(8):1414. doi: 10.1038/s41416-024-02667-x. Br J Cancer. 2024. PMID: 38575733 Free PMC article. No abstract available.
Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest.
Cenigaonandia-Campillo A, Garcia-Bautista A, Rio-Vilariño A, Cebrian A, Del Puerto L, Pellicer JA, Gabaldón JA, Pérez-Sánchez H, Carmena-Bargueño M, Meroño C, Traba J, Fernandez-Aceñero MJ, Baños-Herraiz N, Mozas-Vivar L, Núñez-Delicado E, Garcia-Foncillas J, Aguilera Ó. Cenigaonandia-Campillo A, et al. Among authors: cebrian a. Mol Oncol. 2024 Sep;18(9):2212-2233. doi: 10.1002/1878-0261.13616. Epub 2024 Feb 29. Mol Oncol. 2024. PMID: 38425123 Free PMC article.
98 results